跳至主要内容
临床试验/NCT04088773
NCT04088773进行中(未招募)不适用

Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease

Children's Hospital Medical Center, Cincinnati4 个研究点 分布在 1 个国家目标入组 232 人开始时间: 2019年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
232
试验地点
4
主要终点
Magnetization transfer ratio (MTR)

研究概览

简要总结

This research study will evaluate if specific blood, stool and MRI tests can tell the difference between bowel wall inflammation without scarring and bowel wall inflammation with scarring that can cause bowel blockages requiring surgery.

详细描述

This multi-center study will test the accuracy of individual and combined MRI and blood-based diagnostic tools in both children and adults with small bowel CD. We will determine the accuracy of a composite tool (including its multiple individual biomarkers) for defining the relative amounts of intestinal inflammation versus scarring in patients at the time of surgery (B2 disease) and in patients at an early stage of disease prior to complications (B1 disease).

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
8 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aim 1 (CD participants)
  • Aged 8-70 years
  • Undergoing first surgical distal (ileal) small bowel resection for structuring (B2 phenotype) Crohn's disease as determined by CTE or MRE or ileocolonoscopy
  • English speaking
  • Aim 2 (CD participants)
  • Age 8 to 70 years
  • Uncomplicated inflammatory small bowel CD based on clinical CTE or MRE or ileocolonoscopy performed within 6 months prior to enrollment (CD participants only)
  • English speaking
  • Aim 2 (Control participants)
  • Age 8 to 70 years
  • English speaking

排除标准

  • Aim1 (CD participants)
  • B1 or B3 (i.e., fistula, abscess, phlegmon/inflammatory mass) CD phenotype
  • Prior small bowel surgery, including but not limited to surgical resection, stricturoplasty, or endoscopic treatment of a small bowel stricture
  • Anything to eat or drink within 4 hours of study visit (participants may take their required medications with a little water)
  • Known pregnancy (Note: Institutional policies/procedures will be followed for pregnancy screening)
  • Contraindication for MRI (e.g., surgical implant, claustrophobia). Note: To be determined based on local procedures.
  • Aim 2 (CD participants)
  • Stenotic ileocecal valve at colonoscopy
  • Prior small bowel surgery, including but not limited to surgical resection, stricturoplasty, or endoscopic treatment of a small bowel stricture
  • Anything to eat or drink within 4 hours of study visit (participants may take their required medications with a little water)
  • Known pregnancy (Note: Institutional policies/procedures will be followed for pregnancy screening)
  • Contraindication for MRI (e.g., surgical implant, claustrophobia). Note: To be determined based on local procedures.
  • Aim 2 (Control participants)
  • Any known gastrointestinal tract disease
  • Any known inflammatory/autoimmune disease involving another organ system (e.g., rheumatoid arthritis, scleroderma, multiple sclerosis).
  • Fecal calprotectin level of ˃100 mcg.gm will be excluded from further analysis and replaced.

结局指标

主要结局

Magnetization transfer ratio (MTR)

时间窗: Day 1

compare MTR values between Aim 1 and Aim 2 cohorts

次要结局

  • Correlation between MTR values and bowel wall collagen measurements(Day 1)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验